Latest news
Loading news…
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation.
XOMA was acquired by Ligand Pharmaceuticals in 2026 for $739M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
5
Monthly Visits
Available in Pro Contacts
43
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Emeryville, California, United States
Acquisitions by XOMA
Loading columns…
0 of 0Show
Page 1 / 1
43
professional contacts at XOMA
Contact execs at XOMA →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to XOMA
Loading news…
FAQs about XOMA
People who checked this page also checked these
Sectors XOMA invests & acquires in
Browse the full Acquirezy directory.